双轮驱动视域下粤港澳大湾区跨境医疗健康产业协同发展研究——基于技术赋能与制度嵌套的耦合机制

Research on the Coordinated Development of Cross-Border Medical and Health Industries in the Guangdong-Hong Kong-Macao Greater Bay Area from the Perspective of Dual Wheel Drive—Coupling Mechanism Based on Technology Empowerment and Institutional Nesting

摘要: 在数字经济与健康中国战略深度融合的背景下，粤港澳大湾区依托“人工智能 + 医疗”双轮驱动，构建起跨境医疗健康产业一体化发展的创新范式。2024年7月颁布的《广东省粤港澳大湾区内地九市进口港澳药械管理条例》作为制度突破口，通过精准立法破除政策壁垒，建立跨法域产业协同机制。技术层面，联邦学习框架与区块链智能合约技术深度融合：前者构建多方安全计算网络，实现内地与港澳医疗机构间电子病历、医学影像等敏感信息的动态共享，摆脱数据孤岛困境；后者通过分布式帐本技术构建药械资质认证链，形成涵盖生产、流通、使用全周期的不可篡改追溯体系，使进口药械认证时效提升70%以上。制度创新维度则构建“中央政策引导–湾区法规协同–地方细则落地”三级联动架构，设立跨境医疗联合评审委员会，建立涵盖标准互认、质量追溯、责任划分的全链条监管体系，将三地医疗资质互认周期压缩至传统模式的40%。这种“技术–制度”双螺旋演进模型，不仅重塑了跨境医疗产业生态，更为数字经济时代区域一体化治理提供了创新路径，正推动大湾区迈向世界级智慧健康创新枢纽。

Abstract: In the context of the deep integration of the digital economy and the Healthy China strategy, the Guangdong-Hong Kong-Macao Greater Bay Area relies on the dual wheel drive of “artificial intelligence + healthcare” to build an innovative paradigm for the integrated development of cross-border medical and health industries. The “Regulations on the Administration of Imported Hong Kong and Macao Medicines and Devices in Nine Mainland Cities of the Guangdong-Hong Kong-Macao Greater Bay Area” promulgated in July 2024 serves as a breakthrough point in the system, breaking down policy barriers through precise legislation and establishing cross jurisdictional industrial coordination mechanisms. On the technical level, the deep integration of federated learning framework and blockchain smart contract technology: the former builds a multi-party secure computing network, realizing dynamic sharing of sensitive information such as electronic medical records and medical images between medical institutions in mainland of China and Hong Kong and Macao, and overcoming the dilemma of data silos; The latter uses distributed ledger technology to build a drug and equipment qualification certification chain, forming an immutable traceability system covering the entire production, circulation, and use cycle, which increases the efficiency of imported drug and equipment certification by more than 70%. In terms of institutional innovation, a three-level linkage structure of “central policy guidance-bay area regulatory coordination-local detailed rules implementation” will be constructed, a cross-border medical joint evaluation committee will be established, and a full chain supervision system covering standard mutual recognition, quality traceability, and responsibility division will be established. The mutual recognition cycle of medical qualifications among the three regions will be compressed to 40% of the traditional model. This “technology system” double helix evolution model not only reshapes the cross-border medical industry ecosystem, but also provides an innovative path for regional integration governance in the digital economy era, and is promoting the Greater Bay Area to move towards a world-class smart health innovation hub.